{
    "root": "35cd617a-ce01-adab-e063-6394a90af266",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Clobetasol Propionate",
    "value": "20250523",
    "ingredients": [
        {
            "name": "CETETH-20",
            "code": "I835H2IHHX"
        },
        {
            "name": "CETOSTEARYL ALCOHOL",
            "code": "2DMT128M1S"
        },
        {
            "name": "CITRIC ACID MONOHYDRATE",
            "code": "2968PHW8QP"
        },
        {
            "name": "DIMETHICONE 350",
            "code": "2Y53S6ATLU"
        },
        {
            "name": "IMIDUREA",
            "code": "M629807ATL"
        },
        {
            "name": "ISOPROPYL MYRISTATE",
            "code": "0RE8K4LNJS"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "SODIUM CITRATE, UNSPECIFIED FORM",
            "code": "1Q73Q2JULR"
        },
        {
            "name": "CLOBETASOL PROPIONATE",
            "code": "779619577M"
        }
    ],
    "indications": "Clobetasol propionate cream, 0.05% (emollient) is a super-high potency corticosteroid indicated for:",
    "contraindications": "Apply a thin layer of clobetasol propionate cream, 0.05% (emollient) to the affected skin areas twice daily and rub in gently and completely. Wash hands after each application.\n                  Clobetasol propionate cream, 0.05% (emollient) is a super-high potency topical corticosteroid; therefore,\n \n  treatment should be limited to 2 consecutive weeks, and amounts greater than 50 grams per week should not be used.\n                  \n                  In moderate to severe plaque-type psoriasis, clobetasol propionate cream, 0.05% (emollient) applied to 5% to 10% of body surface area can be used for up to 4 weeks. The total dosage should not exceed 50 grams per week. When dosing for more than 2 weeks, any additional benefits of extending treatment should be weighed against the risk of HPA suppression. Therapy should be discontinued when control has been achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Treatment beyond 4 consecutive weeks is not recommended.\n                  Clobetasol propionate cream, 0.05% (emollient) should not be used with occlusive dressings.",
    "warningsAndPrecautions": "How Supplied\n                        \n                        Clobetasol Propionate Cream USP, 0.05% (Emollient) is a white to off-white cream, supplied in 15 g (NDC 51672-1297-1), 30 g (NDC 51672-1297-2) and 60 g tubes (NDC 51672-1297-3).",
    "adverseReactions": "None"
}